A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age
Clinical trial NCT00657683 · COMPLETED
Trial details
- NCT number
- NCT00657683
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2009-04-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.